Major depressive disorder and bipolar disorder are severe mood disorders that affect the
lives and functioning of millions each year. The majority of previous neurobiological
research and standard pharmacotherapy regimens have approached these illnesses as
purely neurochemical disorders, with particular focus on the monoaminergic
neurotransmitter systems. Not altogether surprisingly, these treatments are inadequate for
many individuals afflicted with these devastating illnesses. Recent advances in functional …